BerndGeorgSchnablMDFAASLD, AGAF
Gastroenterology • San Diego, CAProfessor, Medicine, UCSD School of Medicine
Dr. Schnabl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-8440
Summary
- Dr. Bernd Schnabl is a gastroenterologist based in San Diego, CA. He graduated from Albert Ludwigs University Faculty of Medicine in 1998 and completed his fellowship in gastroenterology at New York Presbyterian Hospital, Columbia University from 2005 to 2008. Dr. Schnabl has an active research profile, with recent publications in various prestigious journals such as Nature, NEJM, Gastroenterology and Journal of Hepatology, focusing on chronic liver disease.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2005 - 2008
Albert Ludwigs University Faculty of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2007 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 5 citationsAcute alcohol-associated hepatitis: Latest findings in non-invasive biomarkers and treatment.Tomoo Yamazaki, Bernd Schnabl
Liver International. 2025-03-01 - Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunities.Yongpeng Shi, Zeran Chen, Tingyu Fang, Xingyao Chen, Youpeng Deng
Imeta. 2025-02-01 - Peroxisome proliferator-activated receptor delta and liver diseases.Tomoo Yamazaki, Edward E Cable, Bernd Schnabl
Hepatology Communications. 2025-02-01
Press Mentions
Alcohol Use Can Alter Gut Microbes, but Not in the Way You Might ThinkAugust 11th, 2022- Liver: Function, Failure & DiseaseFebruary 28th, 2022
- U.S. News & World Report: UC San Diego #1 for Gastroenterology and Hepatology ResearchOctober 28th, 2020
- Join now to see all
Grant Support
- Microbiome And Intestinal Innate Immune Response In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2011
- Blocking Toll-Like Receptor 4 Signaling As Therapy In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
